The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 29, 2018
Filed:
Oct. 14, 2014
Applicant:
Steven A. Rich, Canandaigua, NY (US);
Inventor:
Steven A. Rich, Canandaigua, NY (US);
Assignee:
Other;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/40 (2006.01); A61K 31/20 (2006.01); A61K 31/201 (2006.01); A61K 31/137 (2006.01); A61K 31/216 (2006.01); A61K 31/27 (2006.01); C07D 207/12 (2006.01); C07D 451/00 (2006.01); A61K 31/445 (2006.01); A61K 31/435 (2006.01); A61K 31/4015 (2006.01); A61K 31/438 (2006.01); A61K 31/165 (2006.01); A61K 31/407 (2006.01); A61K 31/202 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/439 (2006.01);
U.S. Cl.
CPC ...
A61K 31/40 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 9/7023 (2013.01); A61K 31/137 (2013.01); A61K 31/165 (2013.01); A61K 31/20 (2013.01); A61K 31/201 (2013.01); A61K 31/202 (2013.01); A61K 31/216 (2013.01); A61K 31/27 (2013.01); A61K 31/407 (2013.01); A61K 31/4015 (2013.01); A61K 31/435 (2013.01); A61K 31/438 (2013.01); A61K 31/439 (2013.01); A61K 31/445 (2013.01); C07D 207/12 (2013.01); C07D 451/00 (2013.01);
Abstract
A method administers quaternary ammonium anti-cholinergic muscarinic receptor antagonists in combination with acetyl-cholinesterase inhibitors to treat either cognitive impairment or acute delirium. This therapy results in a modification of a cognitive disorder or disease, namely a slow down in the disease progression. In one preferred embodiment, the disease is dementia with Lewy Bodies. New formulations for quaternary ammonium anti-cholinergic muscarinic receptor antagonists are also disclosed.